Stocks in Action USA: Sarepta Therapeutics, SoFi, Novo Nordisk

Sarepta Therapeutics (SRPT): Stock Surge After Return of Gene Therapy Elevidys – FDA Lifts Delivery Halt! Shares of Sarepta Therapeutics surged by more than 40% after the biotechnology company announced it would resume delivery of its gene therapy Elevidys . The treatment for ambulatory patients with Duchenne Muscular Dystrophy (DMD) had previously been paused by the U.S. Food and Drug Administration (FDA) due to safety concerns: Two adolescents who received the treatment died from acute liver failure. Additionally, a separate case involving...